Skip to main content
. 2023 Feb 13;16(4):606–617. doi: 10.1111/cts.13472

TABLE 6.

Translation of PD results to humans

Gabapentin
0 mg 50 mg 100 mg 200 mg 400 mg 800 mg
Trazodone (mg)
0 Mean 5.4 10.6 16.4 22.2 28.2
Median 2.51 5.75 10.13 15.5 22.6
1st Q 1.05 2.28 4.13 6.5 9.9
3rd Q 6.43 14.0 23.2 32.7 42.4
0.5 Mean 4.93 21.7 30.0
Median 2.76 17.9 26.2
1st Q 1.18 13.2 20.8
3rd Q 6.03 25.7 36.2
1.0 Mean 9.20 29.1 39.2
Median 5.67 26.0 37.0
1st Q 2.50 20.6 30.4
3rd Q 11.75 33.9 45.7
5 Mean 27.6 58.2 69.4
Median 21.7 57.76 68.8
1st Q 10.5 51.18 64.7
3rd Q 39.6 64.20 73.8
10 Mean 37.5 72.09 81.5
Median 34.1 71.67 81.7
1st Q 18.6 66.83 78.2
3rd Q 53.3 71.67 81.7
25 Mean 56.2
Median 58.7
1st Q 38.4
3rd Q 75.0
50 Mean 69.41
Median 73.96
1st Q 55.09
3rd Q 85.97

Note: Simulation of percentage of inhibition of pain stimulus in humans after single oral ascending doses of trazodone and gabapentin administered alone or in combination. Bold values indicate the low dose combinations of the two compounds indicating enhanced effects when co‐administered.

Abbreviation: PD, pharmacodynamic.